Advance Agrolife Limited has submitted its monitoring agency report on the utilization of IPO proceeds for the quarter ended December 31, 2025, in compliance with SEBI regulations. CARE Ratings Limited, serving as the monitoring agency, confirmed proper utilization of funds with no deviations from stated objectives.

IPO Proceeds Utilization Overview

The company raised ₹192.84 crore through its Initial Public Offering conducted from September 30, 2025, to October 03, 2025. During the quarter ended December 31, 2025, Advance Agrolife utilized ₹98.82 crore across designated objectives, leaving ₹94.02 crore unutilized.

Fund Deployment Across Objectives

The monitoring report details utilization across three primary objectives as outlined in the offer document:

Working Capital Utilization

Advance Agrolife deployed ₹67.50 crore for working capital requirements by transferring funds from the monitoring account to cash credit account. These funds were utilized for supplier payments for raw materials and statutory obligations, including advance tax payments.

General Corporate Purposes

The company utilized ₹8.16 crore towards capital expenditure as approved by the Board of Directors on October 29, 2025. The board resolution covered strategic initiatives, brand building, marketing activities, and capital expenditure requirements.

Deployment of Unutilized Proceeds

The remaining ₹94.02 crore has been strategically deployed in fixed deposits and bank accounts to optimize returns:

Regulatory Compliance and Monitoring

CARE Ratings Limited confirmed no deviations from the objects stated in the offer document. The monitoring agency verified utilization through chartered accountant certificates from S K Patodia & Associates LLP dated February 05, 2026, bank statements, and company declarations.

Company Secretary Nisha Gupta (A42708) digitally signed the regulatory filing on February 12, 2026, ensuring compliance with SEBI LODR Regulations. The report has been made available on the company's website at www.advanceagrolife.com for stakeholder access.

The monitoring report demonstrates Advance Agrolife's systematic approach to IPO proceeds utilization while maintaining regulatory compliance and transparency with stakeholders.

Advance Agrolife Limited has released its comprehensive investor presentation for the third quarter and nine months ended December 31, 2025, in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The presentation was made available following the board meeting held on February 07, 2026, and has been uploaded on the company's website at www.advanceagrolife.com .

Q3FY26 Financial Performance

The company reported total revenue of ₹1338.0 million for Q3FY26, representing an 18% increase compared to ₹1133.8 million in the corresponding quarter of the previous year. Revenue from operations stood at ₹1,328.37 lakhs, marking a 17.36% growth. Net profit for the quarter reached ₹30.1 million, showing an 8% growth from ₹27.7 million in Q3FY25. EBITDA for the quarter increased by 16% to ₹73.5 million with an EBITDA margin of 5.5%.

Nine Months Performance Excellence

For the nine months ended December 31, 2025, Advance Agrolife demonstrated exceptional performance with revenue reaching ₹5153.9 million, marking a robust 25% increase from ₹4127.8 million in the corresponding period last year. Net profit for the nine-month period grew significantly to ₹278.2 million compared to ₹242.1 million in the previous year, representing a 15% growth. EBITDA for nine months rose by 20% to ₹502.5 million with a margin of 9.8%.

Strategic Growth Initiatives

During the quarter, the company established a new R&D laboratory focused on developing innovative product combinations and strengthening its long-term product pipeline. The board approved the installation of a solar power plant with an aggregate capacity of 3.75 MW at Village Bana Ka, Tehsil Osian, District Jodhpur, Rajasthan, for captive consumption to increase renewable energy usage and reduce carbon footprint.

Business Expansion and Market Presence

The company added new B2B customers in its crop protection segment during the quarter, expanding business reach and reinforcing market presence. Advance Agrolife is considering setting up manufacturing facilities for Pretilachlor and PEDA with production capacities of 13 tonnes per day and 10 tonnes per day respectively. The company aims to commence operations at its new Unit-4 technical manufacturing facility at Gidani, Rajasthan by Q2 FY27.

Regulatory Compliance and Transparency

The investor presentation release demonstrates the company's commitment to regulatory compliance and transparent communication with stakeholders. Company Secretary & Compliance Officer Nisha Gupta confirmed the filing under SEBI regulations, ensuring all material information is appropriately disclosed to investors and market participants.